Paper41767232
The osteochondral regeneration paradox: why biomimetic scaffolds are biologically superior but injectable systems dominate the clinic.
Gubert S and 3 others. RSC Adv, 2026. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The osteochondral regeneration paradox: why biomimetic scaffolds are biologically superior but injectable systems dominate the clinic. Papers, record 41767232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41767232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The osteochondral regeneration paradox: why biomimetic scaffolds are biologically superior but injectable systems dominate the clinic.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References155
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21652067 | Enhanced MSC chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. | Biomaterials | 2011 | https://conductscience.org/library/papers/21652067 | PubMed |
| 2 | 22185680 | Growth factors and chondrogenic differentiation of mesenchymal stem cells. | Tissue Cell | 2012 | https://conductscience.org/library/papers/22185680 | PubMed |
| 3 | 33275908 | Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. | Lancet | 2021 | https://conductscience.org/library/papers/33275908 | PubMed |
| 4 | 36493381 | Challenges Facing the Translation of Embryonic Stem Cell Therapy for the Treatment of Cartilage Lesions. | Stem Cells Transl Med | 2022 | https://conductscience.org/library/papers/36493381 | PubMed |
| 5 | 37907031 | Injectable hydrogels: An emerging therapeutic strategy for cartilage regeneration. | Adv Colloid Interface Sci | 2023 | https://conductscience.org/library/papers/37907031 | PubMed |
| 6 | 32929344 | Preparation of high precision multilayer scaffolds based on Melt Electro-Writing to repair cartilage injury. | Theranostics | 2020 | https://conductscience.org/library/papers/32929344 | PubMed |
| 7 | 32776030 | Gradient scaffolds for osteochondral tissue engineering and regeneration. | J Mater Chem B | 2020 | https://conductscience.org/library/papers/32776030 | PubMed |
| 8 | 39589862 | Mechanical and Physical Characterization of a Biphasic 3D Printed Silk-Infilled Scaffold for Osteochondral Tissue Engineering. | ACS Biomater Sci Eng | 2024 | https://conductscience.org/library/papers/39589862 | PubMed |
| 9 | 26069648 | Advances in the Surgical Management of Articular Cartilage Defects: Autologous Chondrocyte Implantation Techniques in the Pipeline. | Cartilage | 2013 | https://conductscience.org/library/papers/26069648 | PubMed |
| 10 | 34901562 | Regulatory perspectives of combination products. | Bioact Mater | 2022 | https://conductscience.org/library/papers/34901562 | PubMed |
| 11 | 40528501 | Unlocking the potential of injectable hydrogels for cartilage repair. | Regen Med | 2025 | https://conductscience.org/library/papers/40528501 | PubMed |
| 12 | 35588688 | In vitro and in vivo investigation of a zonal microstructured scaffold for osteochondral defect repair. | Biomaterials | 2022 | https://conductscience.org/library/papers/35588688 | PubMed |
| 13 | 36550127 | Injectable decellularized cartilage matrix hydrogel encapsulating urine-derived stem cells for immunomodulatory and cartilage defect regeneration. | NPJ Regen Med | 2022 | https://conductscience.org/library/papers/36550127 | PubMed |
| 14 | 33915881 | The Biomechanics of Cartilage-An Overview. | Life (Basel) | 2021 | https://conductscience.org/library/papers/33915881 | PubMed |
| 15 | 19304567 | Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. | Ann Rheum Dis | 2010 | https://conductscience.org/library/papers/19304567 | PubMed |
| 16 | 28711583 | Incidence of symptomatic osteochondritis dissecans lesions of the knee: a population-based study in Olmsted County. | Osteoarthritis Cartilage | 2017 | https://conductscience.org/library/papers/28711583 | PubMed |
| 17 | 9276052 | Cartilage injuries: a review of 31,516 knee arthroscopies. | Arthroscopy | 1997 | https://conductscience.org/library/papers/9276052 | PubMed |
| 18 | 35415286 | Shear-responsive boundary-lubricated hydrogels attenuate osteoarthritis. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35415286 | PubMed |
| 19 | 34589475 | Ex Vivo and In Vivo Properties of an Injectable Hydrogel Derived From Acellular Ear Cartilage Extracellular Matrix. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/34589475 | PubMed |
| 20 | 21984690 | A prospective multicenter study on the outcome of type I collagen hydrogel-based autologous chondrocyte implantation (CaReS) for the repair of articular cartilage defects in the knee. | Am J Sports Med | 2011 | https://conductscience.org/library/papers/21984690 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42557619 | Engineered Injectable Hydrogel Platform for Tailoring the Osteoarthritis Microenvironment. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42557619 | PubMed |
| 42510474 | Predicting Cell Differentiation in Mechanically Stimulated Biphasic Osteochondral Scaffolds Using Fluid-Structure Interaction Modelling. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42510474 | PubMed |
| 42505399 | Design Strategies to Target Joint Resident Mesenchymal Stem Cells for Osteochondral Regeneration. | Cells | 2026 | https://conductscience.org/library/papers/42505399 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41767232
GET https://conductscience.org/api/papers/v1/41767232/references?page=2